Panbela Therapeutics Valor de la empresa
¿Qué es el Valor de la empresa de Panbela Therapeutics?
El Valor de la empresa de Panbela Therapeutics Inc. es $9.68M
¿Cuál es la definición de Valor de la empresa?
El valor empresarial es una medida del valor de mercado total de una empresa. Se calcula como capitalización de mercado con deuda, interés minoritario y acciones preferentes menos el efectivo total y equivalentes de efectivo.
It is a sum of claims by all claimants including creditors (secured and unsecured) and shareholders (preferred and common). Enterprise value is one of the fundamental metrics used in business valuation, financial modeling, accounting, portfolio analysis, and risk analysis. Enterprise value is more comprehensive than market capitalization, which only reflects common equity and is considered more representative of a company’s value. Enterprise value reflects the opportunistic nature of business and may change substantially over time because of both external and internal conditions.
Enterprise value can be negative if the company holds abnormally high amounts of cash that is not reflected in the market value of the stock and total capitalization. Cash is subtracted in the calculation because it reduces the net cost to a potential purchaser. The effect applies whether the cash is used to issue dividends or to pay down debt. Value of minority interest is added because it reflects the claim on assets consolidated into the firm in question. Value of associate companies is subtracted because it reflects the claim on assets consolidated into other firms. EV should also include such special components as unfunded pension liabilities, employee stock options, environmental provisions, abandonment provisions, and so on, since they also reflect claims on the company.
Valor de la empresa de compañías en Sector Health Care en NASDAQ en comparadas con Panbela Therapeutics
¿Qué hace Panbela Therapeutics?
Panbela Therapeutics, Inc., a clinical-stage biopharmaceutical company, together with its subsidiaries, focuses on developing disruptive therapeutics for the treatment of patients with cancer. The company focuses on diseases of the pancreas, including pancreatitis and pancreatic cancer, as well as neoadjuvant pancreatic cancer, colorectal cancer, ovarian cancer, and other agents in other cancer indications. Its lead product candidate is SBP-101, which is in Phase Ia/Ib clinical trial for the treatment of patients with metastatic pancreatic ductal adenocarcinoma. The company was formerly known as Sun BioPharma, Inc. and changed its name to Panbela Therapeutics, Inc. in December 2020. Panbela Therapeutics, Inc. was incorporated in 2011 and is based in Waconia, Minnesota.
Empresas con valor de la empresa similar a Panbela Therapeutics
- Makers Laboratories tiene Valor de la empresa de $9.66M
- Mohit Industries tiene Valor de la empresa de $9.67M
- Peppermint Innovation tiene Valor de la empresa de $9.67M
- Invigor tiene Valor de la empresa de $9.67M
- Curative Biosciences tiene Valor de la empresa de $9.68M
- Surefire Resources NL tiene Valor de la empresa de $9.68M
- Panbela Therapeutics tiene Valor de la empresa de $9.68M
- Oakdale Resources tiene Valor de la empresa de $9.69M
- Viva Gold tiene Valor de la empresa de $9.69M
- Edensoft tiene Valor de la empresa de $9.69M
- InnovaDerma Plc tiene Valor de la empresa de $9.69M
- General Assembly tiene Valor de la empresa de $9.70M
- Redbank Copper tiene Valor de la empresa de $9.71M